Study: When to treat hypertension and intensify treatment
the ONA take:
According to a new study published in the British Medical Journal, researchers at Brigham and Women's Hospital in Boston, Massachusetts, have determined the precise blood pressure level and time points at which intervening with antihypertensives was associated with a decreased risk of death.
Researchers found that that patients with systolic blood pressures between 130 and 150 had no increase in risk, but those with systolic blood pressures above 150 had progressively greater risk of acute cardiovascular event, such as stroke or myocardial infarction, or death.
In addition, they found that delaying intensification of treatment, which was defined as increasing the dosage of antihypertensives or adding new antihypertensives when blood pressure levels increase, by more than 1.4 months was associated with increased risk of cardiovascular event or death.
The team also found that patients who received a blood pressure reassessment more than 2.7 months after treatment intensification had an increased risk of death.
The findings suggest the importance of avoiding treatment delays and follow-up delays for patients with hypertension, particularly those with systolic blood pressure levels greater than 150.
Precise blood pressure level and time points at which intervening with antihypertensives was associated with a decreased risk of death.
Sign Up for Free e-newsletters
- Education May Better Equip Nurses to Hold End-of-Life Conversations in Advanced Cancer
- Avoiding the ED: Planned Strategies for Unplanned Urgent Cancer Care
- NP-Led Clinics Improved Phase 1 Oncology Study Operations, Outcomes
- Art as Palliative Care: Bedside Intervention Improves Pain, Anxiety, Mood in Hospitalized Cancer Patients
- Unprotected Sex After Chemotherapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|